Related Summaries
Statistics

Related Summaries

Other PDQ summaries containing information related to Hodgkin lymphoma include:

• AIDS-Related Lymphoma Treatment.
• Childhood Hodgkin Lymphoma Treatment.

Note: Estimated new cases and deaths from Hodgkin lymphoma in the United States in 2008:[1]

• New cases: 8,220.
• Deaths: 1,350.

More than 75% of all newly diagnosed patients with adult Hodgkin lymphoma (HL) can be cured with combination chemotherapy and/or radiation therapy. National mortality has fallen more rapidly for adult HL than for any other malignancy.

Prognosis for a given patient depends on several factors. The most important factors are the presence or absence of systemic symptoms, the stage of disease, presence of large masses, and the quality and suitability of the treatment administered. Other important factors are age (therapy for very young children requires special attention), sex, erythrocyte sedimentation rate, extent of abdominal involvement, hematocrit, and absolute number of nodal sites of involvement.[2,3]

HL is the main cause of death over the first 15 years after treatment. By 15 to 20 years after therapy, the cumulative mortality from a second malignancy will exceed the cumulative mortality from HL.[4-6]

References

1. American Cancer Society.: Cancer Facts and Figures 2008. Atlanta, Ga: American Cancer Society, 2008. Also available online. Last accessed February 21, 2008. 
   
   
2. American Cancer Society.: Cancer Facts and Figures 2007. Atlanta, Ga: American Cancer Society, 2007. Also available online. Last accessed December 20, 2007. 
   
   
3. Cosset JM, Henry-Amar M, Meerwaldt JH, et al.: The EORTC trials for limited stage Hodgkin's disease. The EORTC Lymphoma Cooperative Group. Eur J Cancer 28A (11): 1847-50, 1992.  [PUBMED Abstract]
   
   
4. Mauch PM, Kalish LA, Marcus KC, et al.: Long-Term Survival in Hodgkin's Disease Cancer J Sci Am 1 (1): 33-42, 1995.  [PUBMED Abstract]
   
   
5. Aisenberg AC: Problems in Hodgkin's disease management. Blood 93 (3): 761-79, 1999.  [PUBMED Abstract]
   
   
6. Aleman BM, van den Belt-Dusebout AW, Klokman WJ, et al.: Long-term cause-specific mortality of patients treated for Hodgkin's disease. J Clin Oncol 21 (18): 3431-9, 2003.  [PUBMED Abstract]
   
   

Back to Top

< Previous Section  |  Next Section >